Janux Therapeutics Inc (JANX)
37.63
-0.29
(-0.76%)
USD |
NASDAQ |
Mar 28, 16:00
37.63
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics Total Assets (Quarterly): 380.41M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 380.41M |
September 30, 2023 | 386.85M |
June 30, 2023 | 341.50M |
March 31, 2023 | 352.96M |
December 31, 2022 | 364.01M |
September 30, 2022 | 375.76M |
June 30, 2022 | 385.36M |
Date | Value |
---|---|
March 31, 2022 | 368.60M |
December 31, 2021 | 379.82M |
September 30, 2021 | 391.08M |
June 30, 2021 | 396.82M |
March 31, 2021 | 71.82M |
December 31, 2020 | 16.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
16.22M
Minimum
Dec 2020
396.82M
Maximum
Jun 2021
323.94M
Average
375.76M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
Viking Therapeutics Inc | 368.49M |
Equillium Inc | 50.53M |
Minerva Neurosciences Inc | 56.90M |
Geron Corp | 394.08M |
Calidi Biotherapeutics Inc | 10.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 36.06M |
Shareholders Equity (Quarterly) | 344.35M |
Current Ratio | 26.80 |